Latest Operating Expenses News

ikeGPS Group reports a robust first half of FY26 with a 47% increase in subscription revenue exit run rate and launches PolePilot™, an AI-driven automation tool enhancing utility network analysis.

ikeGPS has reported a robust first half of FY26 with subscription revenue soaring 47%, a successful A$24 million capital raise, and inclusion in the ASX All Ordinaries Index, underscoring its expanding footprint in the US grid modernization market.

ikeGPS Group reports a robust first half of FY26 with a 47% increase in subscription revenue exit run rate and launches AI-driven PolePilot™ to boost productivity and ARPU.

Zelira Therapeutics has made significant progress in its HOPE 1 clinical trial program, completing a key FDA submission and securing a $650,000 non-dilutive R&D loan facility to support ongoing development and working capital needs.

Cann Group Limited announces a transformative $9 million capital raise alongside a major debt restructure, positioning the medicinal cannabis pioneer for profitability in FY26.

ReadCloud Limited reports a 109% surge in underlying EBITDA to $757k for FY25, driven by robust growth in VET-in-Schools fees and domestic eBook sales, alongside positive cash flow improvements.

OFX Group reports solid progress in migrating corporate clients to its new platform, OFX 2.0, despite a decline in net operating income driven by macroeconomic uncertainty. The fintech’s strategic product launches and client growth signal potential for recovery.

FINEOS Corporation Holdings PLC reports solid Q3 2025 results, highlighting revenue growth, operational efficiencies, and a key North American client migration to its SaaS platform, underpinning positive free cash flow expectations for FY25.

Thor Energy has inked a binding agreement with DISA Technologies to treat uranium waste at its Colorado Projects, leveraging DISA’s newly granted U.S. Nuclear Regulatory Commission license. This deal promises revenue from recovered uranium and critical minerals without upfront costs.

ASX Limited reaffirms its FY26 expense growth guidance while detailing progress on its five-year transformation and addressing regulatory challenges. Strong FY25 financial results and a robust market pipeline underpin the company’s outlook.

ReNerve Limited reported a 38% increase in quarterly sales driven by the launch of its EmpliQ product range and ongoing development of advanced nerve repair technologies. The company’s cash position remains solid as it prepares for upcoming clinical trials.

Bellevue Gold Limited reported robust cash flow for the September quarter, enabling a substantial early repayment on its project loan and maintaining a strong cash position.